Lilly says antibody drug cuts Covid-19 hospitalisation, may seek emergency use nod squib

September 17, 2020 8:20 AM

WASHINGTON (REUTERS) - Eli Lilly and Co on Wednesday (Sept 16) said a single infusion of its experimental antibody treatment reduced the need for hospitalisation and emergency room visits for clinical trial patients with moderate Covid-19.
Scroll for more
Continue reading on The Straits Times...